Systemic complications of fluid resuscitation.
Fluid administration in critically ill individuals is frequently a major component of their therapy. There are important effects on blood pressure and maintenance of cardiac output and oxygen delivery, as detailed elsewhere in this text. There are also potentially negative side effects of this therapy, which have been less well defined. Edema of the gastrointestinal tract has been well described, primarily with crystalloid infusions. Gastrointestinal edema may have very complicated effects on albumin kinetics, fluid flux, and ion flux. It may lead to development of ileus. Increased nasogastric tube output may be incorrectly construed as unremitting obstruction rather than a result of the aforementioned changes and increased crystalloid loads. The relationships of intestinal edema to intestinal absorptive function and diarrhea are less clear. At present, changes in type of fluid infusion or correction of serum albumin level to normal cannot be uniformly recommended. The myocardium, although showing evidence of edema with crystalloid infusion, may appear to benefit from colloidal, osmotically active suspensions in the all too few studies that have been done. To date, there is no study giving evidence of clinically different outcome using a variety of fluids that cause, reduce, or prevent this edema. The presence or absence of myocardial edema may be important in patients who demonstrate decreased ventricular function during sepsis or other disorders in which aggressive fluid administration is routine. Edema of the skin has been associated primarily with decreased oxygen tension. Other studies have shown an association with impaired wound healing or increased risk of infection. A direct causal relationship can only be inferred. We are left with a sense that aggressive fluid resuscitation with crystalloid, although improving oxygen delivery, may have other deleterious effects on organ systems, such as the gastrointestinal tract, myocardium, and integument. The edema resulting from crystalloid administration may lessen or negate the benefits of increased oxygen delivery. Care needs to be taken in interpreting any alteration in organ function with respect to the fluid type and volume being administered. An alternative choice of therapy is lacking at present. The role of colloid has not been as well investigated as that of crystalloid and further study is warranted before any benefits become clear.
Weinstein
P D
PD
Division of Pulmonary and Critical Care Medicine, New York University School of Medicine, New York.
Doerfler
M E
ME
D009202:Cardiomyopathies / Q000209:etiology / Q000503:physiopathology* / Q000517:prevention & control; D000077324:Crystalloid Solutions; D004487:Edema / Q000209:etiology / Q000503:physiopathology* / Q000517:prevention & control; D005440:Fluid Therapy / Q000009:adverse effects*; D005767:Gastrointestinal Diseases / Q000209:etiology / Q000503:physiopathology* / Q000517:prevention & control; D006439:Hemodynamics; D006801:Humans; D007552:Isotonic Solutions; D010952:Plasma Substitutes / Q000009:adverse effects; D012151:Resuscitation / Q000009:adverse effects*; D012871:Skin Diseases / Q000209:etiology / Q000503:physiopathology* / Q000517:prevention & control
D000077324:Crystalloid Solutions; D007552:Isotonic Solutions; D010952:Plasma Substitutes